Word: billionã
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Environmental Science in a Changing World,” Brown sophomores Megan E. Whalen, Matthew L. Wheeler, and Libby Delucia discovered that lead levels in certain campus buildings exceeded the federal limit. The lead content of the water in the applied math building peaked at 150 parts per billion??ten times the legal threshold. But this startling discovery was old news to Brown professor Steven P. Hamburg, formerly a Bullard Fellow at Harvard. “One of the recommendations in an old city like Providence is that you shouldn’t drink water before having...
...many colleges, while tuition is an important source of revenue, it is definitely not the only source–colleges may even spend more per student than they charge in tuition. So it may well be feasible for colleges with large endowments—certainly those exceeding $30 billion??to operate tuition-free. But again, colleges must face the philosophical question he initially posed; Larsen himself comes down strongly on the negative side.“College provides an important service to families and many of them can easily pay,” he says...
HHMI’s endowment now totals $14.8 billion??behind only Harvard, Yale, and Stanford among academic institutions. [SEE CORRECTION BELOW...
...Gates Foundation will spend all of its resources within 50 years of the death of the last member of the board of trustees, consisting of Bill Gates, 51, Melinda French Gates, 42, and Warren E. Buffett, 76, the Foundation announced last week. The foundation, whose endowment will be $63 billion??more than double Harvard’s—when Buffett’s pledge of $31 billion is realized, will direct the money toward promoting global health and development, according to its Web site. To accommodate the new schedule, the foundation will ramp up its payout, aiming...
Further, the tremendous sum that it costs to get a drug approved severely constrains the number of drugs companies are willing to develop. If a pharmaceutical company cannot expect to make back their costs—which could reach over $1 billion??in sales from a drug, it will not even go to the trouble of submitting the drug for FDA approval. This limits the options available to those with rare diseases, because the FDA creates a huge disincentive to make drugs that will only help a “niche” market. That explains...